A Prospective, Single-arm, Multi-center, Open-label Trial Evaluating the Continuous Application of Prevena Therapy for up to 14 Days

Protocol No
SURG-3M-PREVENA
Staff Member
Patrick Murphy
Phase
N/A
Summary

This project is being done to determine if it is beneficial and safe to use the Prevena NPWT Incision Management System beyond 7 days up to 14 days.
Objective
Continuous Treatment With PREVENA Therapy for 14 Days
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Other, Digestive System
ClinicalTrials.gov
https://www.clinicaltrials.gov/study/NCT05614869